Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Common Equity (2023 - 2026)

Adagio Medical Holdings has reported Common Equity over the past 4 years, most recently at $5.7 million for Q1 2026.

  • Quarterly Common Equity fell 53.83% to $5.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Mar 2026, down 53.83% year-over-year, with the annual reading at $12.4 million for FY2025, 37.72% down from the prior year.
  • Common Equity was $5.7 million for Q1 2026 at Adagio Medical Holdings, down from $12.4 million in the prior quarter.
  • Over five years, Common Equity peaked at $76.6 million in Q3 2024 and troughed at -$140.5 million in Q2 2024.
  • The 4-year median for Common Equity is $5.7 million (2026), against an average of -$36.4 million.
  • Year-over-year, Common Equity surged 161.99% in 2024 and then plummeted 101.71% in 2025.
  • A 4-year view of Common Equity shows it stood at -$132.0 million in 2023, then soared by 115.08% to $19.9 million in 2024, then crashed by 37.72% to $12.4 million in 2025, then plummeted by 53.84% to $5.7 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Common Equity are $5.7 million (Q1 2026), $12.4 million (Q4 2025), and -$1.3 million (Q3 2025).